Presence and composition of cathinone derivatives in drug samples taken from a drug test service in Spain (2010-2012)

Human Psychopharmacology

Volumn 28, Issue 4, 2013, Pages 341-344

  Caudevilla Gálligo, Fernando ^a,b   Ventura, Mireia ^b   Indave Ruiz, Blanca Iciar ^b,c   Fornís, Iván ^b  

^a Sociedad Española de Medicina Familiar y Comunitaria SEMFYC   (Spain)

^b Asociacion Bienestar y Desarrollo   (Spain)

^c HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

cathinone derivatives; cathinones; legal highs; mephedrone

Indexed keywords

4' METHYLMETHCATHINONE; AMPHETAMINE DERIVATIVE; BUTYROPHENONE; CATHINONE; KETAMINE; METHAMPHETAMINE; METHYLONE; PYROVALERONE; RECREATIONAL DRUG;

ADULT; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CONFERENCE PAPER; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SPAIN; SUBSTANCE ABUSE; THIN LAYER CHROMATOGRAPHY;

CATHINONE DERIVATIVES; CATHINONES; LEGAL HIGHS; MEPHEDRONE;

ADOLESCENT; ADULT; ALKALOIDS; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, THIN LAYER; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; SPAIN; STREET DRUGS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84880818045     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2296     Document Type: Conference Paper

References (16)

1. Ayres TC, Bond JW,. 2012. A chemical analysis examining the pharmacology of novel psychoactive substances freely available over the internet and their impact on public health. Legal highs or illegal highs? BMJ Open doi: 10.1136/bmjopen-2012-000977.
2. Coppola M, Mondola R,. 2012. 3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208: 12-15.
3. Dargan PI, Albert S, Wood DM,. 2010. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. QJM 103: 875-879.
4. Davies S, Wood DM, Smith G, et al,. 2010. Purchasing 'legal highs' on the Internet - is there consistency in what you get? QJM 103: 489-493.
5. EMCDDA. 2011a. Annual report on the state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
6. EMCDDA. 2011b. EMCDDA-Europol Annual Report on the implementation of Council Decision 2005/387/JHA. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
7. Marusich JA, Grant KR, Blough BE, Wiley JL,. 2012. Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice. Neurotoxicology 33: 1305-1313.
8. Meyer MR, Vollmar C, Schwaninger AE, Wolf E, Maurer HH,. 2012. New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine. J Mass Spectrom 47: 253-262.
9. Prosser JM, Nelson LS,. 2012. The toxicology of bath salts: a review of synthetic cathinones. J Med Toxicol 8: 33-42.
10. Rust KY, Baumgartner MR, Dally AM, Kraemer T,. 2012. Prevalence of new psychoactive substances: a retrospective study in hair. Drug Test Anal 4: 402-408.
11. Sacco L,. 2011. Synthetic Drugs: Overview and Issues for Congress. Congressional Research Service.
12. Simmler LD, Buser TA, Donzelli M, et al,. 2013. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol 168 (2): 458-470.
13. Sorensen LK,. 2011. Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 879: 727-736.
14. UNDOC. 2012. World Drug Report 2012. UNODC, United Nations: Geneva.
15. Wood DM, Greene SL, Dargan PI,. 2012. Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. Eur J Emerg Med 30: 214-217.
16. Zuba D, Byrska B,. 2012. Prevalence and co-existence of active components of 'legal highs'. Drug Test Anal 5: 435-439.